Şunu aradınız:: farmakokinetiku (Slovakça - İngilizce)

farmakokinetiku etravirínu
pharmacokinetics of

farmakokinetiku olanzapínu.
dogs tolerated single oral doses up to 100 mg/ kg without mortality.

vplyv hmotnosti na farmakokinetiku
impact of weight on pharmacokinetics

15 neovplyvňuje farmakokinetiku ritonaviru.
15 range of p450 substrates.

laktácia neovplyvňovala farmakokinetiku duloxetínu.
lactation did not influence duloxetine pharmacokinetics

vplyv telesnej hmotnosti na farmakokinetiku
effect of weight on pharmacokinetics

telitromycín má mierne nelineárnu farmakokinetiku.
telithromycin displays moderate non-linear pharmacokinetics.

potenciál liekov ovplyvniť farmakokinetiku isavukonazolu
potential of medicinal products to affect the pharmacokinetics of isavuconazole

pohlavie nemá vplyv na farmakokinetiku bivalirudínu.
there are no gender effects in the pharmacokinetics of bivalirudin.

Účinok antineoplastických liekov na farmakokinetiku bevacizumabu
effect of antineoplastic agents on bevacizumab pharmacokinetics

zidovudín nemal vplyv na farmakokinetiku lamivudínu.
zidovudine has no effect on the pharmacokinetics of lamivudine.

poškodenie funkcie obličiek neovplyvňuje farmakokinetiku entakaponu.
renal impairment does not affect the pharmacokinetics of entacapone.

lieky ovplyvňujúce farmakokinetiku ivakaftoru: inhibítory cyp3a
medicinal products affecting the pharmacokinetics of ivacaftor: cyp3a inhibitors

pohlavie: pohlavie nemá vplyv na farmakokinetiku palonosetronu.
8 gender: gender does not affect the pharmacokinetics of palonosetron.

sildenafil neovplyvňuje farmakokinetiku sakvinaviru (pozri časť4.2).
sildenafil had no effect on saquinavir pharmacokinetics (see section 4.2).